ALKERMES | Ativo Circulante



Current Assets Alterar Data
AbbVie USD 27.68B 2.09B 2025-03
Acadia Pharmaceuticals USD 960.55M 89.61M 2025-06
ALKERMES USD 1.64B 156.24M 2025-06
Amgen USD 26.73B 195M 2025-06
Biogen USD 7.97B 341.7M 2025-06
BioMarin Pharmaceutical USD 3.81B 337.43M 2025-06
Bristol-Myers Squibb USD 33.22B 2.44B 2025-06
Eli Lilly USD 49.85B 8.59B 2025-06
Gilead Sciences USD 14.72B 2.18B 2025-06
Ionis Pharmaceuticals USD 2.58B 158.22M 2025-06
J&J USD 71.55B 15.66B 2025-03
Malin Corporation EUR 62.6M 26.7M 2024-12
Merck USD 37.07B 1.56B 2025-06
Neurocrine Biosciences USD 1.75B 111M 2025-06
Otsuka Holdings JPY 1.39T 72.73B 2025-06
Pfizer USD 43.7B 2.16B 2025-06
Regeneron Pharmaceuticals USD 16.86B 712.2M 2025-06
Vertex Pharmaceuticals USD 10.43B 419.1M 2025-06


ALKERMES Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Aug 2025.